SHCBP1 drives tumor progression in triple-negative breast cancer

SHCBP1 drives tumor progression in triple-negative breast cancer

BackgroundsTriple-negative breast cancer (TNBC) represents the most aggressive breast cancer subtype. The limited treatment options underscore the urgent need to explore novel molecular targets to combat TNBC progression. This study investigates the oncogenic functions of SHCBP1 in TNBC.Materials an...

Full description

Saved in:

Bibliographic Details
Main Authors:	Huiling Wang, Huijuan Dai, Liheng Zhou, Yanping Lin, Wenjin Yin, Jingsong Lu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Oncology
Subjects:	SHCBP1 single-cell RNA-seq triple negative breast cancer proliferation migration
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1587236/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Malic enzyme 2 promotes liver cancer progression by regulating SHCBP1
by: QIU Yuchong, DU Wenjing
Published: (2025-06-01)

Ursolic acid suppresses triple-negative breast cancer progression through mediating FABP4/PPARG pathway
by: Ying Deng, et al.
Published: (2025-07-01)

Ferroptosis-related genes mediate tumor microenvironment and prognosis in triple-negative breast cancer via integrated RNA-seq analysis
by: Xuantong Gong, et al.
Published: (2025-06-01)

Interleukin-12 Inhibits Tumor Growth and Metastasis Promoted by Tumor-Associated Mesenchymal Stem Cells in Triple-Negative Breast Cancer
by: Babak Jahangiri, et al.
Published: (2024-09-01)

Plasma exosomes in insulin resistant obesity exacerbate progression of triple negative breast cancer
by: Pablo Llévenes, et al.
Published: (2025-07-01)

Blood mononuclear cell molecular landscape associated with tumor progression in triple-negative breast cancer
by: M. R. Patysheva, et al.
Published: (2023-11-01)

PCSK9 Promotes the Malignancy of Triple‐negative Breast Cancer Cells by Reducing Cholesterol Levels at the Plasma Membrane to Activate EGFR and HER3
by: Tianhong Li, et al.
Published: (2025-05-01)

Tumor-derived exosomal lncRNA SNHG4 promotes triple-negative breast cancer progression by targeting XPO5
by: Zhi-Wen Wang, et al.
Published: (2025-06-01)

Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma: Relationship With Prognostic Factors and Response to Neoadjuvant Chemotherapy
by: Özgen Arslan Solmaz, et al.
Published: (2025-01-01)

Immune microenvironment and prognostic genes of triple-negative breast cancer in the context of transcriptome and single-cell sequencing
by: Xiangqin Huang, et al.
Published: (2025-08-01)

In Silico Perspectives on Triple Negative Breast Cancer: Challenges and Progress
by: Maham Taqi, et al.
Published: (2025-06-01)

Black seed oil inhibits the migration of triple‐negative breast cancer cells and regulates MMP‐9 expression
by: Ghina Lintangsari, et al.
Published: (2025-03-01)

Triple-negative breast cancer: Pattern of recurrence and survival outcomes
by: Shyny Reddy Chintalapani, et al.
Published: (2019-01-01)

LncRNA FAISL Inhibits Calpain 2‐Mediated Proteolysis of FAK to Promote Progression and Metastasis of Triple Negative Breast Cancer
by: Yunmei Zhang, et al.
Published: (2024-11-01)

ARID1B Gene Deletion Promotes the Proliferation, Migration and Invasion  of NSCLC Cells
by: Linlin ZHU, et al.
Published: (2025-03-01)

Development of a prognostic model based on the ceRNA network in Triple-Negative Breast cancer
by: Yimin Zhu, et al.
Published: (2025-02-01)

α9 Nicotinic Acetylcholine Receptor Promotes Tumor Proliferation and Suppresses Ferroptosis in Triple-Negative Breast Cancer
by: Xiaoli Feng, et al.
Published: (2025-06-01)

Unlocking the epigenetic code: new insights into triple-negative breast cancer
by: Gowthami Mahendran, et al.
Published: (2024-12-01)

c-MYC Levels and Metabolic Parameters in Triple-Positive and Triple-Negative Breast Cancer
by: Doaa N. Abood, et al.
Published: (2025-06-01)

Results of combination treatment for triple-negative breast cancer
by: M. A. Sekundova, et al.
Published: (2014-07-01)

Role of Glucocorticoid Receptor in Triple-Negative Breast Cancer
by: Raj Kumar
Published: (2025-04-01)

Molecular genetic predictors of progression of triple negative breast cancer
by: I. S. Panchenko, et al.
Published: (2025-03-01)

The novel tRNA-derived fragment, tiRNA-Met, inhibits the malignant progression of triple-negative breast cancer by regulating RANBP3L via a targeted interaction with SNRPA
by: Jingjing Lu, et al.
Published: (2025-05-01)

Adipocytes-induced ANGPTL4/KLF4 axis drives glycolysis and metastasis in triple-negative breast cancer
by: Dou Yin, et al.
Published: (2025-07-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01)

DLAT promotes triple-negative breast cancer progression via YAP1 activation
by: Diya Liu, et al.
Published: (2024-12-01)

Single-cell RNA sequencing reveals SLC31A1-mediated M2 polarization of macrophages promotes malignant progression in triple-negative breast cancer
by: Xiwei Zhang, et al.
Published: (2025-05-01)

Diagnostic utility of ultrasound features in identifying triple-negative breast cancer
by: Jampana Sahitya, et al.
Published: (2025-05-01)

LncRNA NRAD1 regulates the triple-negative breast cancer transcriptome by miRNA biogenesis, localization, and predominately non-ceRNA interactions
by: Hannah F. Cahill, et al.
Published: (2025-07-01)

Caveolin-1 in Tumour Cells is Predominately Expressed in the Basal Subtype of Triple-Negative Breast Carcinoma
by: Savelina Popovska, et al.
Published: (2014-11-01)

Clinical Significance of Tumor Grade in Triple-Negative Breast Cancer: A Retrospective Cohort Analysis
by: Neya Ramanan, et al.
Published: (2025-05-01)

Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple‐negative breast cancer
by: Laura Pascual‐Reguant, et al.
Published: (2023-11-01)

Single-cell Atlas reveals core function of CPVL/MSR1 expressing macrophages in the prognosis of triple-negative breast cancer
by: Xinan Wang, et al.
Published: (2024-12-01)

Therapeutic limitations of oncolytic VSVd51-mediated miR-199a-5p delivery in triple negative breast cancer models
by: Guillaume St-Cyr, et al.
Published: (2025-05-01)

Tumor-infiltrating lymphocytes in triple negative breast cancer
by: L. M. Zakhartseva, et al.
Published: (2020-12-01)

Eribulin Effectiveness and Safety in Metastatic Triple-Negative Breast Cancer: A Narrative Review
by: Herleeyana Meriyani, et al.
Published: (2025-02-01)

Network pharmacological analysis and in vitro testing of the rutin effects on triple-negative breast cancer
by: Chang Cheng, et al.
Published: (2025-01-01)

Leptomeningeal metastasis in triple-negative breast cancer: a retrospective study
by: Yun-Yi Wang, et al.
Published: (2025-08-01)

Development of a prognostic model based on four genes related to exhausted CD8+ T cell in triple-negative breast cancer patients: a comprehensive analysis integrating scRNA-seq and bulk RNA-seq
by: Yulin Shi, et al.
Published: (2025-02-01)

The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer
by: Chikako Funasaka, et al.
Published: (2025-01-01)